Yes David is not going to be able to make a failed trial a success, but in biotech it is all about risk verse reward. As long as you don't YOLO into a biotech and the price is low enough compared to the upside, then it can be worth the risk.
- Forums
- ASX - By Stock
- DXB
- Ann: Dimerix Appoints Chief Medical Officer
Ann: Dimerix Appoints Chief Medical Officer, page-7
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $211.7M |
Open | High | Low | Value | Volume |
38.0¢ | 38.0¢ | 37.0¢ | $246.4K | 658.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
10 | 262775 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 32276 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 195263 | 0.370 |
12 | 1397167 | 0.365 |
6 | 59089 | 0.360 |
3 | 52619 | 0.355 |
9 | 102527 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 32276 | 2 |
0.385 | 30000 | 1 |
0.390 | 25524 | 3 |
0.395 | 161740 | 3 |
0.400 | 141398 | 5 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |